Iafa Keydar

Tel Aviv University — Israel

Medicine · Health Sciences

33h-index4.3kcitations69works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(36), Glycosylation and Glycoproteins Research(23), Immunotherapy and Immune Responses(19), Virus-based gene therapy research(14), HER2/EGFR in Cancer Research(8)

Publications69 total

774 Focal facial dermal dysplasia type I caused by a duplication on 1p36.22
Journal of Investigative Dermatology·2018
immunologically related to a group of mouse mammary tumor virus (immunoperoxidase staining/paraffin sections/cancer antigen)
2016
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: A basis for tumor-promoting interactions
Cytokine·2008· 90 cited
Human Endogenous Retrovirus (HERV-K) Reverse Transcriptase as a Breast Cancer Prognostic Marker
Neoplasia·2008· 102 citedOpen Access
Antibody internalization studied using a novel IgG binding toxin fusion
Journal of Immunological Methods·2007· 66 cited
The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients
Clinical Cancer Research·2006· 147 citedOpen Access
MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Molecular Cancer·2006· 78 citedOpen Access
A Novel Protein Derived from the MUC1 Gene by Alternative Splicing and Frameshifting
Journal of Biological Chemistry·2004· 34 citedOpen Access
A Unique Mucin Immunoenhancing Peptide with Antitumor Properties
Cancer Research·2004· 15 cited
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors
Cancer Letters·2004· 100 cited
Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity
Molecular Immunology·2004· 13 cited
Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.
PubMed·2002· 20 cited
Generation of ligand‐receptor alliances by “SEA” module‐mediated cleavage of membrane‐associated mucin proteins
Protein Science·2002· 111 citedOpen Access
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.
PubMed·2002· 336 cited
Functional Analysis of Csk and CHK Kinases in Breast Cancer Cells
Journal of Biological Chemistry·2001· 44 citedOpen Access
Characterization of a hormonally induced reverse transcriptase (RT) from the human breast cancer cell line T47D: a possible involvement in human breast cancer
Breast Cancer Research·2001· 1 citedOpen Access
Protection against growth of MUC1/sec transfected mammary tumor cells is mediated by an effector cell with perforin-dependent cytotoxicity
Breast Cancer Research·2001Open Access
The CC chemokine RANTES as a potential contributor to breast cancer progression
Breast Cancer Research·2001· 3 citedOpen Access
RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion
Oncogene·2000· 95 cited
Analysis of the promoter of the MUC1 gene overexpressed in breast cancer
FEBS Letters·1999· 33 cited
page 1 of 4Next →

Frequent Co-authors

Daniel H. Wreschner(18), Nechama I. Smorodinsky(9), Sheila Zrihan‐Licht(9), Joseph Z. Zaretsky(8), Amos Baruch(8), Ricardo Mesa‐Tejada(8), Sima Shina(7), Ilan Tsarfaty(7), Mordechai Weiss(7), Tsuneya Ohno(7), S. Spiegelman(7), Adit Ben‐Baruch(6), Samario Chaitchik(6), Mara Hareuveni(6), M Ramanarayanan(6), Cecilia M. Fenoglio(5), Amnon Hizi(5), Elina Azenshtein(4), Hava Avraham(4), Shulamith Karby(3)